Acute Kidney Injury Clinical Trial Pipeline Highlights 2019 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global
Acute Kidney Injury Clinical Trial Pipeline Highlights – 2019”
report has been added to ResearchAndMarkets.com’s
offering.

Acute Kidney Injury Pipeline Highlights – 2019, provides most up-to-date
information on key pipeline products in the global Acute Kidney Injury
market. It covers emerging therapies for Acute Kidney Injury in active
clinical development stages including early and late stage clinical
trials. The pipeline data presented in this report helps executives for
tracking competition, identifying partners, evaluating opportunities,
formulating business development strategies, and executing in-licensing
and out-licensing deals.

Clinical Trial Stages:

The report provides Acute Kidney Injury pipeline products by clinical
trial stages including both early and late stage development – phase 3
clinical trials, phase 2 clinical trials, phase 1 clinical trials,
preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Acute Kidney Injury pipeline products by their
dominant mechanism of action/drug class. This helps executives
categorize products based on their drug class and also assess the
strengths and weaknesses of compounds.

Company:

The report provides Acute Kidney Injury pipeline products by the company.

Short-term Launch Highlights:

Find out which Acute Kidney Injury pipeline products will be launched in
the US and Ex-US till 2024.

Summary:

• Acute Kidney Injury phase 3 clinical trial pipeline products
• Acute Kidney Injury phase 2 clinical trial pipeline products
• Acute Kidney Injury phase 1 clinical trial pipeline products
• Acute Kidney Injury preclinical research pipeline products
• Acute Kidney Injury discovery stage pipeline products
• Acute Kidney Injury pipeline products short-term launch highlights

Key Topics Covered:

1. Acute Kidney Injury Pipeline by Stages

2. Acute Kidney Injury Phase 3 Clinical Trial Insights

3. Acute Kidney Injury Phase 2 Clinical Trial Insights

4. Acute Kidney Injury Phase 1 Clinical Trial Insights

5. Acute Kidney Injury Preclinical Research Insights

6. Acute Kidney Injury Discovery Stage Insights

7. Appendix

8. Research Methodology

For more information about this report visit https://www.researchandmarkets.com/r/kvs5e

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Clinical
Trials, Liver
and Kidney Disorders Drugs